PROSPERI, ENNIO
 Distribuzione geografica
Continente #
AS - Asia 2.572
NA - Nord America 1.706
SA - Sud America 513
EU - Europa 435
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 2
Totale 5.284
Nazione #
US - Stati Uniti d'America 1.596
SG - Singapore 1.248
CN - Cina 448
BR - Brasile 407
HK - Hong Kong 350
VN - Vietnam 231
FR - Francia 155
KR - Corea 75
CA - Canada 67
IT - Italia 64
GB - Regno Unito 48
DE - Germania 40
IN - India 40
BD - Bangladesh 39
JP - Giappone 36
AR - Argentina 30
NL - Olanda 24
EC - Ecuador 23
BE - Belgio 18
MX - Messico 18
LT - Lituania 17
ZA - Sudafrica 17
ID - Indonesia 15
CO - Colombia 13
UA - Ucraina 13
IL - Israele 11
MA - Marocco 11
TR - Turchia 11
CL - Cile 10
RU - Federazione Russa 10
SA - Arabia Saudita 10
PY - Paraguay 9
VE - Venezuela 9
ES - Italia 8
AE - Emirati Arabi Uniti 7
FI - Finlandia 7
JM - Giamaica 7
IQ - Iraq 6
PE - Perù 6
PK - Pakistan 6
UZ - Uzbekistan 6
EG - Egitto 5
KE - Kenya 5
PH - Filippine 5
AT - Austria 4
KZ - Kazakistan 4
NP - Nepal 4
SE - Svezia 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
AL - Albania 3
IE - Irlanda 3
RO - Romania 3
TW - Taiwan 3
BO - Bolivia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
JO - Giordania 2
KG - Kirghizistan 2
MY - Malesia 2
OM - Oman 2
PA - Panama 2
PL - Polonia 2
PR - Porto Rico 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BW - Botswana 1
BY - Bielorussia 1
DZ - Algeria 1
GH - Ghana 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
LB - Libano 1
LC - Santa Lucia 1
MM - Myanmar 1
MN - Mongolia 1
NO - Norvegia 1
PF - Polinesia Francese 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SN - Senegal 1
SV - El Salvador 1
TZ - Tanzania 1
VC - Saint Vincent e Grenadine 1
XK - ???statistics.table.value.countryCode.XK??? 1
YT - Mayotte 1
Totale 5.278
Città #
Santa Clara 759
Singapore 750
Hong Kong 344
San Jose 191
Hefei 172
Lauterbourg 149
Ashburn 102
Ho Chi Minh City 96
Seoul 70
Beijing 63
Los Angeles 51
Hanoi 42
São Paulo 35
Toronto 31
Dallas 25
Frankfurt am Main 25
Tokyo 24
Buffalo 17
Brussels 16
Da Nang 15
New York 15
Ottawa 13
Rio de Janeiro 12
Guangzhou 11
Amsterdam 10
Atlanta 10
Johannesburg 10
London 10
Minamishinagawa 10
Quito 10
Milan 9
Dhaka 8
Orem 8
Belo Horizonte 7
Bengaluru 7
Brooklyn 7
Curitiba 7
Guayaquil 7
Miami 7
Brasília 6
Campinas 6
Goiânia 6
Ha Long 6
Helsinki 6
Istanbul 6
Jakarta 6
Montreal 6
Sassari 6
Bắc Ninh 5
Charlotte 5
Chicago 5
Dubai 5
Guarulhos 5
Haiphong 5
Houston 5
Mauá 5
Porto Alegre 5
Recife 5
Salvador 5
Santo André 5
Tashkent 5
Asunción 4
Biên Hòa 4
Cairo 4
Dayton 4
Durban 4
Fortaleza 4
Hải Dương 4
Kingston 4
Lima 4
Manchester 4
Mumbai 4
Nairobi 4
Naples 4
New Delhi 4
Ninh Bình 4
Philadelphia 4
Phủ Lý 4
Quận Bảy 4
Ribeirão Preto 4
Riyadh 4
Rome 4
São Bernardo do Campo 4
The Dalles 4
Thái Nguyên 4
Barbianello 3
Bauru 3
Buenos Aires 3
Cary 3
Cincinnati 3
Ciudad del Este 3
Denver 3
Düsseldorf 3
Elk Grove Village 3
Fargo 3
Florence 3
Formosa 3
Guro-gu 3
Hangzhou 3
Heilbronn 3
Totale 3.415
Nome #
Assessing Cell Cycle Independent Function of the CDK Inhibitor p21(CDKN¹A) in DNA Repair 87
Proliferating cell nuclear antigen complex formation induced by ultraviolet irradiation in human quiescent fibroblasts as detected by immunostaining and flow cytometry. 71
Histochemical model studies of enzyme activity after thermal damage. 66
p21(waf1/cip1)-null human fibroblasts are deficient in nucleotide excision repair downstream the recruitment of PCNA to DNA repair sites. 64
Human proliferating cell nuclear antigen, poly(ADP-ribose) polymerase-1, and p21waf1/cip1. A dynamic exchange of partners. 62
PCNA acetylation by CBP/p300 links its degradation to DNA repair synthesis 60
Revisiting the Function of p21CDKN1A in DNA Repair: The Influence of Protein Interactions and Stability 59
DNA damage response: multiple roles for p21CDKN1A. 57
Single Cell Determination of 7,8-dihydro-8-oxo-2'-deoxyguanosine by Fluorescence Techniques: Antibody vs. Avidin Labeling 57
Dynamics of protein binding to sites of nascent unscheduled DNA repair synthesis in non-proliferating cells 55
Targeting Proliferating Cell Nuclear Antigen (PCNA) as an Effective Strategy to Inhibit Tumor Cell Proliferation. 54
p21CDKN1A and DNA Repair Systems: Recent Findings and Future Perspectives 50
Effects of isolation conditions on the cytometric evaluation of chromatin structure in rat myocardial nuclei. 49
Transcriptional stress induces chromatin relocation of the nucleotide excision repair factor XPG 47
CREBBP and p300 lysine acetyl transferases in the DNA damage response 46
CBP/p300-mediated acetylation of PCNA is required for its chromatin removal and degradation in nucleotide excision repair 46
Generation of the Rubinstein-Taybi syndrome type 2 patient-derived induced pluripotent stem cell line (IAIi001-A) carrying the EP300 exon 23 stop mutation c.3829A > T, p.(Lys1277*) 46
2-methoxyestradiol: New perspectives in colon carcinoma treatment. 46
In situ analysis of DNA-protein complex formation upon radiation-induced DNA damage 45
In Vitro Neurotoxicity of Flumethrin Pyrethroid on SH-SY5Y Neuroblastoma Cells: Apoptosis Associated with Oxidative Stress 44
Correlation between ultrastructural and histochemical parameters in lymphokine-activated killer (LAK) cells reacting with target cells in vitro. 43
Investigating the role of p300 and CBP in Nucleotide Excision Repair: interaction with NER factors. 43
Biology of the cell cycle inhibitor p21(CDKN1A): molecular mechanisms and relevance in chemical toxicology. 43
DNA damage accumulation and response in Down syndrome cell model systems 43
A damaged DNA binding protein 2 mutation disrupting interaction with proliferating-cell nuclear antigen affects DNA repair and confers proliferation advantage 43
Involvement of the cell cycle inhibitor p21CDKN1A in DNA repair. 42
An improved method for the detection of nucleotide excision repair factors at local UV DNA damage sites 42
Immunocytometric determination of the alpha and beta isoforms of human DNA topoisomerase II: influence of different fixatives. 42
Generation of three iPSC lines (IAIi002, IAIi004, IAIi003) from Rubinstein-Taybi syndrome 1 patients carrying CREBBP non sense c.4435G>T, p.(Gly1479*) and c.3474G>A, p.(Trp1158*) and missense c.4627G>T, p.(Asp1543Tyr) mutations. 42
Evidence of the role of PARP-1 - p21 complex in DNA repair 41
CBP and p300 acetylate PCNA to link its degradation with nucleotide excision repair synthesis 41
Rubinstein-Taybi syndrome lymphoblastoid cells show oncreased sensitivity to oxidative DNA damage 41
Dynamics of p21CDKN1A recruitment to DNA repair sites depends on the interaction with PCNA 40
Comparative studies on the effects of Doxorubicin and differentiation inducing agents on B16 melanoma cells 40
Pirazolcarbossiamidi e morte cellulare: una nuova arma per la chemioterapia. 40
PCNA, PARP-1 and p21: a dynamic exchange of partners. 40
Modulation of p21CDKN1A protein levels by anticancer agents: a double-edged sword to fight genome instability. 40
A functional in vitro cell-free system for studying DNA repair in isolated nuclei 40
Exploring new potential role of DDB2 by host cell reactivation assay in human tumorigenic cells 39
Differential involvement of DNases in HeLa cell apoptosis induced by etoposide and long term-culture. 38
p21CDKN1A regulates the binding of poly (ADP-Ribose) polymerase-1 to DNA repair intermediates 38
Small ribosomal subunits associate with nuclear myosin and actin in transit to the nuclear pores. 38
DNA stainability with base-specific fluorochromes: dependence on the DNA topology in situ. 38
p21 regulates the affinity of PARP-1 for damaged DNA 38
Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. 37
The cyclin-dependent inhibitor p21CDKN1A as a target of anti-cancer drugs. 37
The resveratrol analogue 4,4'-dihydroxy-trans-stilbene inhibits cell proliferation with higher efficiency but different mechanism from resveratrol. 37
PAR-mediated death response to oxidative stress in human cybrid models of Parkinson disease 37
Regulation of PARP-1 activity during Base Excision Repair: the role of p21CDKN1A 37
p300/CBP acetyl transferases interact with and acetylate the nucleotide excision repair factor XPG. 37
Nuclear binding of cell cycle-related proteins: cyclin A versus proliferating cell nuclear antigen (PCNA). 36
p21(CDKN1A) participates in base excision repair by regulating the activity of poly(ADP-ribose) polymerase-1 36
A functional in vitro cell-free system for studying DNA repair in isolated nuclei 36
Cytoplasmatic hybrids (PD cybrids) as a model system to investigate genome stability in Parkinson's disease 36
Role of the protein p21CDKN1A (Waf1/Cip1) in the DNA replication and repair pathways. 35
Degradation of p21(CDKN1A) after DNA damage is independent of type of lesion, and is not required for DNA repair. 35
Increase in p21CDKN1A protein levels by protesome inhibitors does not affect the apoptotic response after DNA damage. 35
An active mechanism flanks and modulates the export of the small ribosomal subunits. 35
DDB2 mutant protein unable to interact with PCNA promotes cell cycle progression of human transformed embryonic kidney cells 35
The acetyltranferases p300/CBP interact with, and acetylate XPG protein in nucleotide excision repair. 35
Delayed entry to quiescence by p21CDKN1A-null human fibroblasts: a possible involvement in the disassembly of pre-replication complex 34
Early recruitment of a pool of p21CDKN1A protein to nucleotide excision repair sites in human cells 34
A basic role for p21CDKN1A in the DNA damage response by regulation of PCNA interaction with proteins involved in chromatin modification 34
Defective DNA repair and increased chromatin binding of DNA repair factors in Down syndrome fibroblasts. 33
p21waf1/cip1 protein associates with the detergent-insoluble form of PCNA concomitantly with disassembly of PCNA at nucleotide excision repair sites. 33
Flow cytometric evaluation of DNA digestion with S1 nuclease. 33
ENDOGENOUS DNA DAMAGE AND DNA REPAIR DEFICIENCY IN DOWN SYNDROME FIBROBLASTS 33
p21 modulates PARP-1 recruitment to DNA repair sites. XIX Convegno Nazionale "I processi di ADP-ribosilazione" 33
Mutations in CREBBP and EP300 genes affect DNA repair of oxidative damage in Rubinstein-Taybi syndrome cells. 32
A variant of the Nijmegen breakage syndrome with unusual cytogenetic features and intermediate cellular radiosensitivity. 32
Flow cytometric analysis of DNA sensitivity to nuclease S1 in UVC-irradiated human fibroblasts. 32
Cellular response to etoposide in H2AX deficient immortalized mouse embryonic fibroblasts. 32
Effects of topoisomerase II inhibitors on gastric cancer cells characterized by different genetic lesions. 31
Etoposide induces the dispersal of DNA ligase I from replication factories. 31
Nuclear localisation of p21CDKN1A does not affect PCNA-dependent nucleotide excision repair in human cells 31
p21CDKN1A does not interfere with loading of PCNA at DNA replication sites, but inhibits subsequent binding of DNA polymerase delta at the G1/S phase transition. 31
Expression of the 170-kDa and 180-kDa isoforms of DNA topoisomerase II in resting and proliferating human lymphocytes. 31
The spin trap alpha-phenyl-tert-butyl nitrone protects against myelotoxicity and cardiotoxicity of adriamycin while preserving the cytotoxic activity. 31
Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response. 30
Analysis of proliferating cell nuclear antigen (PCNA) associated with DNA excision repair sites in mammalian cells. 30
Marcatori di proliferazione nucleare 30
Effect of a new arylthioindole on HeLa cell metabolism. 30
DNA sensitivity to S1 nuclease detected by base-specific fluorochromes. 30
Helicobacter pylari releases a factor(s) inhibiting cell cycle progression of human gastric cell lines by affecting cyclin E/cdk2 activity and Rb protein phosphorylation through enhanced p27 (KIP1) protein expression. 30
Cell cycle distribution of propteins involved in pre-replication versus dna replication as analysed by flow cytometry 29
Activation of poly(ADP-ribose)polymerase in apoptotic human cells. 29
Anthocyanins protect against oxidative damage in cell cultures 28
Identification of a new tubulin inhibitor that kills cancer cells 28
Dynamics of fluorescent protein-tagged p21CDKN1A and PCNA recruitment to dna repair sites 28
Proliferating cell nuclear antigen bound to DNA synthesis sites: phosphorylation and association with cyclin D1 and cyclin A. 28
Involvement of the proliferating cell nuclear antigen (PCNA) in DNA repair induced by alkylating agents and oxidative damage in human fibroblasts. 28
Analysis of p21CDKN1A recruitment to DNA excision repair foci in the UV-induced DNA damage response. 27
Parameters influencing the flow cytometric analysis of DNA sensitivity to nuclease S1. 27
The MUS81 endonuclease processes stalled replication forks into DSBs in the absence of WRN 27
Apoptosis-prone phenotype of human colon carcinoma cells with a high level amplification of the c-myc gene. 26
Expression of P21CDKN1A does not affect PCNA-dependent nucleotide excision repair in human cells 26
Cyclins: relevance of subcellular localization in cell cycle control. 26
Effect of the topoisomerase II inhibitor Etoposide on H2AX deficient immortalized mouse embryonic fibroblasts. 26
A study of cross-resistance pattern and expression of molecular markers of multidrug resistance in a human small-cell lung-cancer cell line selected with doxorubicin. 25
Influence of Daunorubicin on membrane permeability properties: detection by means of intracellular accumulation and efflux of fluorescein 25
Totale 3.856
Categoria #
all - tutte 18.731
article - articoli 12.209
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 976
Totale 31.916


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20246 0 0 0 0 0 0 0 0 2 0 1 3
2024/20252.251 3 13 158 95 708 185 32 35 18 20 510 474
2025/20262.877 93 190 291 458 566 127 482 188 153 99 113 117
2026/2027150 136 14 0 0 0 0 0 0 0 0 0 0
Totale 5.284